A detailed history of Bamco Inc transactions in Illumina, Inc. stock. As of the latest transaction made, Bamco Inc holds 383,621 shares of ILMN stock, worth $51.4 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
383,621
Previous 334,407 14.72%
Holding current value
$51.4 Million
Previous $34.9 Million 43.31%
% of portfolio
0.14%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$105.28 - $135.9 $5.18 Million - $6.69 Million
49,214 Added 14.72%
383,621 $50 Million
Q2 2024

Aug 14, 2024

BUY
$101.05 - $133.57 $6.27 Million - $8.29 Million
62,043 Added 22.78%
334,407 $34.9 Million
Q1 2024

May 15, 2024

BUY
$127.73 - $147.2 $513,857 - $592,185
4,023 Added 1.5%
272,364 $37.4 Million
Q4 2023

Feb 14, 2024

BUY
$92.79 - $142.53 $5.41 Million - $8.31 Million
58,331 Added 27.78%
268,341 $37.4 Million
Q3 2023

Nov 14, 2023

SELL
$128.91 - $192.44 $25.9 Million - $38.6 Million
-200,733 Reduced 48.87%
210,010 $28.8 Million
Q2 2023

Aug 14, 2023

SELL
$183.43 - $232.67 $11.5 Million - $14.5 Million
-62,488 Reduced 13.2%
410,743 $77 Million
Q1 2023

May 15, 2023

SELL
$193.75 - $232.55 $16.7 Million - $20.1 Million
-86,236 Reduced 15.41%
473,231 $110 Million
Q4 2022

Feb 14, 2023

SELL
$187.24 - $242.74 $3.18 Million - $4.12 Million
-16,980 Reduced 2.95%
559,467 $113 Million
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $1.45 Million - $1.86 Million
-8,162 Reduced 1.4%
576,447 $110 Million
Q2 2022

Aug 15, 2022

BUY
$181.58 - $368.0 $23.8 Million - $48.3 Million
131,328 Added 28.97%
584,609 $108 Million
Q1 2022

May 13, 2022

SELL
$303.87 - $423.8 $8.06 Million - $11.2 Million
-26,513 Reduced 5.53%
453,281 $158 Million
Q4 2021

Feb 14, 2022

SELL
$347.28 - $421.83 $2.25 Million - $2.73 Million
-6,473 Reduced 1.33%
479,794 $183 Million
Q3 2021

Nov 12, 2021

SELL
$405.61 - $524.84 $19.1 Million - $24.8 Million
-47,207 Reduced 8.85%
486,267 $197 Million
Q2 2021

Aug 13, 2021

SELL
$372.84 - $481.5 $11.5 Million - $14.9 Million
-30,945 Reduced 5.48%
533,474 $252 Million
Q1 2021

May 19, 2021

SELL
$361.28 - $504.76 $13.7 Million - $19.1 Million
-37,923 Reduced 6.3%
564,419 $217 Million
Q4 2020

Feb 12, 2021

BUY
$292.7 - $370.96 $22.7 Million - $28.8 Million
77,641 Added 14.8%
602,342 $223 Million
Q3 2020

Nov 13, 2020

BUY
$268.51 - $400.74 $3.57 Million - $5.33 Million
13,289 Added 2.6%
524,701 $162 Million
Q2 2020

Aug 14, 2020

BUY
$256.46 - $373.01 $11.2 Million - $16.3 Million
43,726 Added 9.35%
511,412 $189 Million
Q1 2020

May 15, 2020

BUY
$209.2 - $335.53 $1.51 Million - $2.42 Million
7,220 Added 1.57%
467,686 $128 Million
Q4 2019

Feb 18, 2020

BUY
$288.29 - $335.49 $215,929 - $251,282
749 Added 0.16%
460,466 $153 Million
Q3 2019

Nov 14, 2019

BUY
$266.84 - $378.23 $1.95 Million - $2.76 Million
7,302 Added 1.61%
459,717 $140 Million
Q2 2019

Aug 15, 2019

BUY
$300.59 - $368.15 $4.52 Million - $5.54 Million
15,049 Added 3.44%
452,415 $167 Million
Q1 2019

May 15, 2019

BUY
$272.57 - $321.18 $3.08 Million - $3.63 Million
11,310 Added 2.65%
437,366 $136 Million
Q4 2018

Feb 14, 2019

BUY
$272.46 - $366.54 $5.2 Million - $7 Million
19,096 Added 4.69%
426,056 $128 Million
Q3 2018

Nov 14, 2018

SELL
$279.04 - $367.06 $6.37 Million - $8.38 Million
-22,830 Reduced 5.31%
406,960 $149 Million
Q2 2018

Aug 14, 2018

BUY
$228.17 - $292.07 $2.1 Million - $2.69 Million
9,210 Added 2.19%
429,790 $120 Million
Q1 2018

May 09, 2018

BUY
$209.54 - $253.91 $1.22 Million - $1.48 Million
5,846 Added 1.41%
420,580 $99.4 Million
Q4 2017

Feb 14, 2018

SELL
$202.23 - $230.03 $5.99 Million - $6.81 Million
-29,601 Reduced 6.66%
414,734 $90.6 Million
Q3 2017

Nov 15, 2017

BUY
$172.3 - $213.93 $76.6 Million - $95.1 Million
444,335
444,335 $88.5 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.1B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Bamco Inc Portfolio

Follow Bamco Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.